Back to search results

Pharmacy-led Intervention for Medication Adherence

This study is testing a program called "Med AAAction" to help people with multiple long-term health conditions like diabetes, high blood pressure, high cholesterol, coronary artery disease, and heart failure take their medications as prescribed after leaving the hospital. The Med AAAction program offers medications with no copay, delivers medications to your bedside and then to your home, and provides care coordination from pharmacy technicians or health coaches. The goal is to see if this program helps people stick to their medication schedule over 12 months. This study is for adults aged 21 or older who are on Medicaid or uninsured, have at least two of these chronic conditions, and receive their chronic disease medications from the hospital pharmacy. The current status of this study is unclear.

Study design
This is an interventional study planning to enroll 388 participants. It is not specified if it is randomized or blinded.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Your medication adherence will be measured at 3, 6, 9, and 12 months after starting the program.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06374277

Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence

Recruiting
NAAges 18+InterventionalHealth services
University of Tennessee
~388 participants
Updated 2026-01-29 on ClinicalTrials.gov
What's tested:Med AAAction intervention

At a glance

Recruiting sites
1 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Adherence to chronic disease medications
Measured over Adherence measured at 3, 6, 9, and 12 months

Conditions

Diabetes
Hypertension
High Cholesterol/Hyperlipidemia
Coronary Artery Disease
Congestive Heart Failure
Chronic Lung Disease
Chronic Kidney Diseases
Arrythmia
Stroke
Depression
Anxiety
Pulmonary Embolism
Heart Attack

Explore related trials

AnxietyArrhythmiaChronic Kidney DiseaseChronic Lung DisorderCongestive Heart FailureCoronary Artery DiseaseDepressionDiabetes MellitusHyperlipidemiaHypertensionMyocardial InfarctionPulmonary EmbolismStroke

Where it's being run

2 sites across 1 states
Tennessee2

Study leadership

  • Satya Surbhi, PhD · PRINCIPAL_INVESTIGATOR · UTHSC

Who to contact

Satya Surbhi, PhD
[email protected]
646-438-0919
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Medicaid or uninsured inpatients
21 years or older
≥2 of the complex chronic conditions during index admission or prescribed/using ≥2 chronic medications for these conditions
Patients receiving chronic disease medications from the hospital pharmacy.
Patients will be eligible if they have multiple complex chronic conditions including diabetes, hypertension, high cholesterol, coronary artery disease, congestive heart failure, chronic lung disease, chronic kidney disease, arrhythmia, stroke, psychiatric disorders including depression and anxiety, or who are prescribed or using anticoagulants.

Exclusion

Medicare and Medicaid dual eligible patients.
If the primary reason for the index admission is related to cancer, pregnancy, or a surgical procedure for an acute problem
If patients have diagnoses of active psychosis, substance abuse, or suicidal ideation during the index admission.
If the planned discharge location is not home.
If patients are part of an existing pharmacy discharge program.

What this trial measures

  • Adherence to chronic disease medicationsAdherence measured at 3, 6, 9, and 12 months

    Adherence to oral chronic disease medications will be assessed for the groups every 3 months using the pill count method (primary method). Additionally, we will measure patient self-reported adherence to chronic disease medications at 3-month, 6-month, and 12-month follow-up by using the following question "On how many of the last seven days, did you take your recommended medication" for each of their chronic disease medications (secondary method).